WallStreetZen

NYSE: ABT
Abbott Laboratories Stock Forecast, Predictions & Price Target

Analyst price target for ABT

Based on 9 analysts offering 12 month price targets for Abbott Laboratories.
Min Forecast
$116.00+5%
Avg Forecast
$126.67+14.65%
Max Forecast
$140.00+26.72%

Should I buy or sell ABT stock?

Strong Buy
Strong Buy
5 analysts 55.56%
Buy
3 analysts 33.33%
Hold
1 analysts 11.11%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ABT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Anonymous
BTIG
Strong BuyMaintains$120.00+8.62%2021-06-02
Cecilia Furlong
Morgan Stanley
Strong BuyMaintains$126.00+14.05%2021-06-02
Joanne Wuensch
Citigroup
Strong BuyMaintains$125.00+13.14%2021-06-02
Travis Steed
Barclays
Strong BuyMaintains$125.00+13.14%2021-06-02
Marie Thibault
BTIG
Strong BuyUpgrades$140.00+26.72%2021-01-28
Matt Miksic
Credit Suisse
BuyMaintains$120.00+8.62%2021-06-02
Jayson Bedford
Raymond James
BuyMaintains$116.00+5.00%2021-06-02
Joshua Jennings
Cowen & Co.
BuyMaintains$140.00+26.72%2021-01-28
Danielle Antalffy
SVB Leerink
HoldMaintains$128.00+15.86%2021-01-28

1 of 1

Forecast return on equity

Is ABT forecast to generate an efficient return?
Company
30.19%
Industry
25.15%
Market
61.34%
ABT's Return on Equity is forecast to be high in 3 years (30.19%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ABT forecast to generate an efficient return on assets?
Company
14.01%
Industry
14.31%
Market
18.93%
ABT is forecast to generate lower Return on Assets (14.01%) than the US Medical Devices industry average (14.31%)
Forecast

ABT earnings per share forecast

What is ABT's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$4.35+35.9%
Avg 2 year Forecast
$4.86+52%
Avg 3 year Forecast
$5.22+63.06%
ABT's earnings are forecast to grow at a rate of 18.04% per year, which is not exceptional
Forecast

ABT revenue forecast

What is ABT's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$40.0B+7.03%
Avg 2 year Forecast
$39.5B+5.8%
Avg 3 year Forecast
$41.8B+11.93%
ABT's revenue is forecast to grow at a rate of 3.33% per year, which is not exceptional
Forecast

ABT earnings growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?
Company
18.04%
Industry
41.31%
Market
19.57%
ABT's earnings are forecast to grow slower (18.04% per year) than the US Medical Devices industry average (41.31%)
Forecast
ABT's earnings are forecast to grow slower (18.04% per year) than the US market average (19.57%)
Forecast
ABT's earnings are forecast to grow faster (18.04% per year) than the risk-free savings rate (1.5%)
Forecast

ABT revenue growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?
Company
3.33%
Industry
9.99%
Market
14.55%
ABT's revenues are forecast to grow slower (3.33% per year) than the US Medical Devices industry average (9.99%)
Forecast
ABT's revenues are forecast to grow slower (3.33% per year) than the US market average (14.55%)
Forecast

Abbott Laboratories Stock Forecast FAQ

Is Abbott Laboratories Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: ABT) stock is to Strong Buy ABT stock.

Out of 9 analysts, 5 (55.56%) are recommending ABT as a Strong Buy, 3 (33.33%) are recommending ABT as a Buy, 1 (11.11%) are recommending ABT as a Hold, 0 (0%) are recommending ABT as a Sell, and 0 (0%) are recommending ABT as a Strong Sell.

What is ABT's earnings growth forecast for 2021-2023?

(NYSE: ABT) Abbott Laboratories's forecast annual earnings growth rate of 18.04% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 41.31%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.57%.

Abbott Laboratories's earnings in 2021 is $5,724,000,000.On average, 8 Wall Street analysts forecast ABT's earnings for 2021 to be $7,727,035,460, with the lowest ABT earnings forecast at $7,640,326,636, and the highest ABT earnings forecast at $7,853,545,054. On average, 10 Wall Street analysts forecast ABT's earnings for 2022 to be $8,642,453,200, with the lowest ABT earnings forecast at $8,084,531,673, and the highest ABT earnings forecast at $9,772,510,814.

In 2023, ABT is forecast to generate $9,271,447,532 in earnings, with the lowest earnings forecast at $9,008,478,150 and the highest earnings forecast at $9,417,146,784.

What is ABT's revenue growth forecast for 2021-2023?

(NYSE: ABT) Abbott Laboratories's forecast annual revenue growth rate of 3.33% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.99%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.55%.

Abbott Laboratories's revenue in 2021 is $37,338,000,000.On average, 7 Wall Street analysts forecast ABT's revenue for 2021 to be $71,008,413,957,836, with the lowest ABT revenue forecast at $68,892,079,015,957, and the highest ABT revenue forecast at $74,380,889,671,546. On average, 7 Wall Street analysts forecast ABT's revenue for 2022 to be $70,188,450,549,578, with the lowest ABT revenue forecast at $67,027,999,230,488, and the highest ABT revenue forecast at $73,164,656,280,240.

In 2023, ABT is forecast to generate $74,258,004,790,111 in revenue, with the lowest revenue forecast at $70,993,950,641,832 and the highest revenue forecast at $76,881,230,983,812.

What is ABT's forecast return on assets (ROA) for 2021-2024?

(NYSE: ABT) forecast ROA is 14.01%, which is lower than the forecast US Medical Devices industry average of 14.31%.

What is ABT's Price Target?

According to 9 Wall Street analysts that have issued a 1 year ABT price target, the average ABT price target is $126.67, with the highest ABT stock price forecast at $140.00 and the lowest ABT stock price forecast at $116.00.

On average, Wall Street analysts predict that Abbott Laboratories's share price could stay at $126.67 by Jun 2, 2022. The average Abbott Laboratories stock price prediction forecasts a potential downside of N/A from the current ABT share price of $110.48.

What is ABT's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: ABT) Abbott Laboratories's current Earnings Per Share (EPS) is $3.20. On average, analysts forecast that ABT's EPS will be $4.35 for 2021, with the lowest EPS forecast at $4.30, and the highest EPS forecast at $4.42. On average, analysts forecast that ABT's EPS will be $4.86 for 2022, with the lowest EPS forecast at $4.55, and the highest EPS forecast at $5.50. In 2023, ABT's EPS is forecast to hit $5.22 (min: $5.07, max: $5.30).

What is ABT's forecast return on equity (ROE) for 2021-2024?

(NYSE: ABT) forecast ROE is 30.19%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.